We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Molecular Imaging Transforms Prostate Cancer Management

By MedImaging International staff writers
Posted on 02 Apr 2020
Image: The Siemens Healthineers Biograph Horizon PET/CT (Photo courtesy of Siemens Healthineers)
Image: The Siemens Healthineers Biograph Horizon PET/CT (Photo courtesy of Siemens Healthineers)
Prostate-specific membrane antigen (PSMA) positron emission tomography computed tomography (PET-CT) improves prostate cancer staging accuracy, claims a new study.

Researchers at the University of Melbourne (UNIMELB; Melbourne, Australia), the University of Western Australia (UWA; Crawley, Australia), and other institutions conducted a study involving 300 men at ten sites across Australia diagnosed with prostate cancer and deemed to be at high risk. The men were randomly assigned to receive either conventional CT and bone scans (152 patients) or PSMA-PET/CT (148 patients). The CT produces detailed body images, while the PET scan detects areas where PSMA is present at high levels, indicating the presence of prostate cancer cells.

The results showed that PSMA-PET/CT scans were much more accurate (92%) than conventional CT and bone scans (65%) at detecting cancer spread. Conventional imaging failed to detect cancer spread in 29 patients, giving a false negative result. By comparison, PSMA-PET/CT gave false negative results in just six patients; furthermore, fewer men had false positive results. While both imaging techniques involved radiation exposure, the dose associated with PSMA-PET/CT was less than half (8.4mSv) of conventional imaging (19.2mSv).

In addition, PSMA-PET/CT scans had greater impact on the way the patients' disease was managed, with 28% having their treatment plans changed following scans, compared with 15% following conventional imaging. And when PSMA-PET/CT was introduced at the second round of imaging (after conventional imaging), disease management plans were still changed in 27% of cases, but when conventional imaging was used at the second round, however, just 5% of patients had their treatment plans changed. The study was published on March 20, 2020, in The Lancet.

“Taken together, our findings indicate that PSMA-PET/CT scans offer greater accuracy than conventional imaging and can better inform treatment decisions,” said lead author Professor Michael Hofman, MBBS, of the Peter MacCallum Cancer Centre at UNIMELB. “We recommend that clinical guidelines should be updated to include PSMA PET/CT as part of the diagnostic pathway for men with high risk prostate cancer.”

PET is a nuclear medicine imaging technique that produces a three dimensional (3D) image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide tracer. Tracer concentrations within the body are then reconstructed in 3D by computer analysis. In modern PET-CT scanners, 3D imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.

Related Links:
University of Melbourne
University of Western Australia


New
Mammography System (Analog)
MAM VENUS
New
High-Precision QA Tool
DEXA Phantom
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
X-ray Diagnostic System
FDX Visionary-A

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.